Key Takeaways:
Oura Health Oy, the maker of a popular smart ring that tracks sleep and fitness, has confidentially filed for a U.S. initial public offering, seeking to capitalize on a fourfold revenue surge and a valuation of over $11 billion in a market crowded by tech giants.
"We've earned the trust of millions of people around the world to help them understand some of their most personal health signals," CEO Tom Hale said in a recent press release, highlighting the company's evolution from a sleep tracker to a broader health intelligence platform.
The company has sold over 5.5 million rings and is on track to surpass five million paid subscribers this quarter. Oura projects revenues could reach $1.5 billion in 2026, a significant jump from its 2024 sales. The IPO is being led by Goldman Sachs and Morgan Stanley, according to a person familiar with the matter.
Oura’s public offering will be the largest in the consumer wearables space since Peloton’s 2019 debut and will serve as a key test of investor appetite for hardware-plus-subscription models. The filing’s details on customer retention and the split between hardware sales and its $5.99 monthly membership will be critical for Wall Street to determine whether to value Oura as a high-margin tech platform or a cyclical hardware maker.
The filing comes as the U.S. IPO market shows signs of recovery, led by high-profile tech names. AI hardware firm Cerebras recently completed the biggest tech offering since 2019, while filings from SpaceX and OpenAI are highly anticipated. Oura’s listing, alongside a confidential filing from fitness app Strava, suggests a potential reopening of the IPO window for consumer-facing tech companies that benefited from the pandemic-era wellness boom.
Founded in 2013, Oura established the smart ring category with a device that appeals to users seeking less intrusive health tracking than a smartwatch. Its high-profile user base, including Prince Harry and numerous professional athletes, has helped it gain visibility. However, competition is intensifying. Samsung launched its Galaxy Ring this year, and Apple is reportedly developing its own ring, adding to the formidable challenge posed by the Apple Watch. Google's Fitbit and fellow unicorn Whoop, valued at $10.1 billion, are also vying for market share in the crowded wearables sector.
Oura's success hinges on its ability to defend its niche through superior health-tracking technology and a recurring revenue model. The company has expanded its focus to preventative health, incorporating AI and analytics for metabolic health, stress, and women's health. For investors, the key question will be the durability of its subscription revenue. The public prospectus will offer the first detailed look at gross margins and churn rates, metrics that will ultimately decide if Oura can sustain its premium valuation against some of the world's largest technology companies.
This article is for informational purposes only and does not constitute investment advice.
